News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Handed a Federal Subpoena Over Nucynta Marketing


8/5/2013 7:19:31 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson said in a filing with the Securities and Exchange Commission that federal investigators in Atlanta are examining the company's sales tactics, including payments to health-care providers, for its opioid painkillers, Nucynta IR and Nucynta ER. J&J filed its second quarter financial report (10-Q, here) on Friday. The item on the subpoena is on page 34. J&J's Janssen Pharmaceuticals makes Nucynta and got the subpoena from the Atlanta regional Office of the Department of Health and Human Services, Office of Inspector General.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES